Cargando…
A preliminary study on treatment of human breast cancer xenografts with a cocktail of paclitaxel, doxorubicin, and (131)I-anti-epithelial cell adhesion molecule (9C4)
Triple-negative breast cancer often has devastating outcomes and treatment options remain limited. Therefore, different treatment combinations are worthy of testing. The efficacy of a cocktail of paclitaxel, doxorubicin, and (131)I-anti-epithelial cell adhesion molecule (EpCAM) (9C4) to treat breast...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357706/ https://www.ncbi.nlm.nih.gov/pubmed/30774541 http://dx.doi.org/10.4103/wjnm.WJNM_9_18 |